Northern Trust’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.24M | Sell |
|
|||||
|
2025
Q2 | $1.02M | Buy |
|
|||||
|
2025
Q1 | $95.8K | Hold |
|
|||||
|
2024
Q4 | $155K | Buy |
|
|||||
|
2024
Q3 | $153K | Sell |
|
|||||
|
2024
Q2 | $160K | Sell |
|
|||||
|
2024
Q1 | $292K | Sell |
|
|||||
|
2023
Q4 | $210K | Buy |
|
|||||
|
2023
Q3 | $155K | Buy |
|
|||||
|
2023
Q2 | $206K | Sell |
|
|||||
|
2023
Q1 | $181K | Buy |
|
|||||
|
2022
Q4 | $180K | Hold |
|
|||||
|
2022
Q3 | $163K | Sell |
|
|||||
|
2022
Q2 | $206K | Sell |
|
|||||
|
2022
Q1 | $1.53M | Sell |
|
|||||
|
2021
Q4 | $2.66M | Sell |
|
|||||
|
2021
Q3 | $3.33M | Sell |
|
|||||
|
2021
Q2 | $4.22M | Sell |
|
|||||
|
2021
Q1 | $5.29M | Buy |
|
|||||
|
2020
Q4 | $3.44M | Sell |
|
|||||
|
2020
Q3 | $3.53M | Sell |
|
|||||
|
2020
Q2 | $4.74M | Sell |
|
|||||
|
2020
Q1 | $4.41M | Buy |
|
|||||
|
2019
Q4 | $4.66M | Buy |
|
|||||
|
2019
Q3 | $4.12M | Buy |
|
|||||
|
2019
Q2 | $6.13M | Buy |
|
|||||
|
2019
Q1 | $5.83M | Buy |
|
|||||
|
2018
Q4 | $8.15M | Sell |
|
|||||
|
2018
Q3 | $10M | Buy |
|
|||||
|
2018
Q2 | $10M | Buy |
|
|||||
|
2018
Q1 | $9.19M | Sell |
|
|||||
|
2017
Q4 | $6.82M | Sell |
|
|||||
|
2017
Q3 | $5.99M | Buy |
|
|||||
|
2017
Q2 | $4.91M | Buy |
|
|||||
|
2017
Q1 | $4.01M | Sell |
|
|||||
|
2016
Q4 | $2.58M | Buy |
|
|||||
|
2016
Q3 | $3.39M | Buy |
|
|||||
|
2016
Q2 | $1.02M | Buy |
|
|||||
|
2016
Q1 | $951K | Buy |
|
|||||
|
2015
Q4 | $1.53M | Buy |
|